LBF20406HO09: Difference between revisions
No edit summary |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=DFA8127 | |LipidBank=DFA8127 | ||
|LipidMaps=LMFA03060023 | |LipidMaps=LMFA03060023 | ||
|SysName=3R- | |SysName=3R-Hydroxy- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoic acid | ||
|Common Name=&&3R- | |Common Name=&&3R-Hydroxy- (5Z,8Z,11Z,14Z) -eicosatetraenoic acid&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Symbol=3(R)-HETE | |Symbol=3(R)-HETE | ||
|Biological Activity=3(R)-HETE enhances the formation of platelet activating factor and release of arachidonic acid from human | |Biological Activity=3(R)-HETE enhances the formation of platelet activating factor and release of arachidonic acid from human neutrophils <!--8152-->. | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 16:24, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8127 |
| LipidMaps | LMFA03060023 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406HO09 |
| 3R-Hydroxy- (5Z,8Z,11Z,14Z) -eicosatetraenoic acid | |
|---|---|
| |
| Structural Information | |
| 3R-Hydroxy- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoic acid | |
| |
| 3(R)-HETE | |
| Formula | C20H32O3 |
| Exact Mass | 320.23514489 |
| Average Mass | 320.46628 |
| SMILES | OC(CC=CCC=CCC=CCC=CCCCCC)CC(O)=O |
| Physicochemical Information | |
| 3(R)-HETE enhances the formation of platelet activating factor and release of arachidonic acid from human neutrophils . | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
